铂力特于7月8日晚间公告，公司2025年4月披露的2024年年报和2025年一季报存在多处错误，违反了《上市公司信息披露管理办法》第三条第一款的规 定，陕西证监局决定对公司、董事长兼总经理薛蕾、财务总监梁可晶采取出具警示函的行政监管措施。 在此之前，铂力特于6月10日晚间回复此前上交所对公司下发的2024年报告的信息披露监管问询函，就公司关于收入变动合理性、应收款项变动、在建工 程及预付款项等进行了说明。 回复公告披露，铂力特对2023年年报、2024年一季报、半年报、三季报以及2024年业绩快报进行会计差错更正，主要涉及收入、成本、利润、应收账款、 存货等报表项目。上交所要求公司说明本次对各定期报告及业绩快报进行会计差错更正的具体情况，同时说明相关报告期是否还存在其他类似情形。铂力 特在回复函中表示，出现相关会计差错的主要原因是公司财务人员对会计准则的理解不到位，对合同识别错误，以及收入确认的依据存在瑕疵，导致部分 收入确认出现差错。 资料显示，铂力特主营业务是金属3D打印设备及产品的研发、生产和销售，主要产品是选择性激光熔化成形、激光立体成形、电弧增材制造等系列金属 3D打印设备等。 12月31日晚，铂力 ...

Core Viewpoint - The company, *ST Panda, is facing significant financial challenges, including a major revision of its profit forecast for 2024, which now indicates a substantial loss instead of a profit, raising concerns about its financial stability and compliance with regulatory standards [4][9]. Financial Performance - The initial profit forecast for 2024 was estimated to be between 30 million to 45 million yuan, indicating a potential profit compared to the previous year [4][9]. - Following a self-examination, the company announced a credit impairment loss of 580 million yuan on other receivables and current assets, leading to a revised profit forecast indicating a net loss of between 460 million to 480 million yuan for 2024 [4][9]. - The auditing firm, Lianda CPA, issued an audit report with no opinion due to significant fluctuations in profits and large losses over the past three years, establishing a materiality threshold of 13 million yuan for the consolidated financial statements [4][9]. Regulatory Issues - On December 29, 2025, the company received a notice from the China Securities Regulatory Commission regarding an investigation into alleged violations of information disclosure laws [2][7]. - There are two potential compensation periods for investors: one for those who bought shares between January 23, 2025, and April 27, 2025, and another for those who purchased shares before December 29, 2025, and sold or continued to hold them after December 30, 2025 [5][10].

Core Viewpoint - Panda Financial Holdings Co., Ltd. is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, following a series of financial irregularities and management issues [1][4]. Financial Irregularities - The company's 2024 financial statements received an audit report that could not express an opinion, and internal controls have been given negative opinions for five consecutive years, highlighting issues such as unauthorized use of seals and chaotic small loan operations [4]. - In 2024, the company provided a pledge guarantee for 300 million yuan of term deposits without board approval, later replacing the funds and fully recognizing impairment losses [4]. - An additional 176 million yuan was reported to have flowed out under the guise of procurement and acquisition payments, with unverified destinations [4]. Management Issues - The actual controller, Zhao Weiping, was arrested in 2022 for illegal public deposit absorption, leading to the freezing of all his shares [4]. - The company's 2024 performance forecast shifted from profit to loss, indicating serious discrepancies in the earnings forecast [4]. Investor Compensation - Affected investors who purchased shares between December 2, 2024, and April 27, 2025, and held them can voluntarily register for compensation through the "Sina Investor Rights Protection Platform," regardless of whether they sold shares after April 28, 2025 [2][5].

Core Viewpoint - ST HuLuWa is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure, leading to a significant drop in stock price and market capitalization [1][2]. Group 1: Investigation Background - This is not the first time ST HuLuWa has faced issues with information disclosure, having previously received criticism for inaccurate financial data in multiple reports [2]. - The company's chairman, Liu Jingping, has been criticized for failing to timely disclose the 2024 annual performance forecast, indicating serious internal control and financial compliance issues [2]. Group 2: Financial Performance Decline - ST HuLuWa's financial performance has deteriorated sharply since 2024, with total revenue of 1.414 billion yuan, a year-on-year decrease of 21.26%, and a net loss of 274 million yuan, a decline of over 2600% [3]. - In the first three quarters of 2025, the company reported revenue of 683 million yuan, down 33.88%, and a net loss of 11.21 million yuan [3]. - Due to internal control issues, the company received an audit report that could not express an opinion, leading to its stock being classified as a "ST stock" from April 30, 2025 [3]. Group 3: Shareholder Equity Freeze - The controlling shareholder, Hainan HuLuWa Investment Development Co., Ltd., has had 23.9 million shares frozen, representing 5.97% of the total share capital, due to a triggered early redemption clause [4]. - The freezing of shares is often seen as a signal of governance and liquidity risks, which could lead to forced share reductions or changes in control if debt issues are not resolved [4]. - ST HuLuWa is currently facing compounded pressures from regulatory investigations, operational losses, and shareholder equity freezes, raising concerns about its future stability and market confidence [4].

公司于2025年12月12日收到中国证监会湖北监管局下发的《行政处罚事先告知书》（鄂处罚字〔2025〕 8号），具体内容详见公司于2025年12月13日披露的《人福医药集团股份公司关于收到中国证券监督管 理委员会湖北监管局〈行政处罚事先告知书〉的公告》（公告编号：临2025-128号）。 公司及相关责任人于2025年12月29日收到中国证监会湖北监管局出具的《行政处罚决定书》（〔2025〕 10号），现将相关情况公告如下： 一、《行政处罚决定书》主要内容 当事人：人福医药集团股份公司（以下简称人福医药），住所：湖北省武汉市东湖高新区。 武汉当代科技产业集团股份有限公司（以下简称当代集团），住所：湖北省武汉市东湖新技术开发区。 艾路明，男，195×年5月出生，时任当代集团董事，住址：湖北省武汉市洪山区。 登录新浪财经APP 搜索【信披】查看更多考评等级 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 人福医药集团股份公司（以下简称"公司"）及原控股股东武汉当代科技产业集团股份有限公司（以下简 称"当代科技"）于2024年10月2 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 一、正式处罚落地 12月29日，ST人福（维权）公告，公司及控股股东收到湖北监管局的《行政处罚事先告知书》，公司 及相关主体涉嫌多项信息披露违法违规行为，涉及非经营性资金占用、关联交易未披露、年报虚假记载 等多方面问题。 监管对人福医药公司处以850万元罚款；对原控股股东当代集团处以900万元罚款；相关责任人同步领 罚。 因此引发的投资者索赔事宜，上海沪紫律师事务所刘鹏律师团队代理的案件已按顺序陆续递交立案，还 在征集受损投资者中。 二、存在巨额资金占用 湖北证监局调查认定的违法事实，揭示了人福医药及其原控股股东"当代集团"在数年间的一系列违规操 作。 2020年至2022年期间，ST人福及当代集团存在多项违法事实：一是非经营性资金占用累计127.85亿元未 及时披露，且2020年年度报告遗漏该信息；二是2022年3月下属子公司与关联方16.45亿元物业资产交易 未及时披露，且未载入当年年报；三是2020年至2022年半年度多份财报存在虚假记载，累计虚增归母净 利润超3亿元；四是当代集团隐瞒关联关系，导致公司1亿元股权收购交易未按规定披露关联信息。 监管部门的 ...

Core Viewpoint - *ST Panda (600599.SH) experienced a significant drop today, closing at 10.45 yuan, following a series of five trading limit increases over the past eight trading days, with sell orders exceeding 130,000 lots [1] Group 1: Regulatory Actions - The company received a "Notice of Investigation" from the China Securities Regulatory Commission (CSRC) on December 29, 2025, due to suspected violations of information disclosure laws [1] - The CSRC has decided to initiate an investigation against the company based on the Securities Law of the People's Republic of China and the Administrative Penalty Law [1] Group 2: Company Operations - Despite the ongoing investigation, the company's production and operational activities are reported to be functioning normally [1] - The company will actively cooperate with the CSRC during the investigation and will adhere to relevant laws and regulatory requirements for timely information disclosure [1]

登录新浪财经APP 搜索【信披】查看更多考评等级 上海久诚律师事务所投资者索赔律师许峰提示，倍轻松（维权）（688793）涉嫌虚假陈述引发的投资者 索赔案已经启动。（许峰律师专栏） 除了倍轻松投资者索赔案启动，2025年12月29日，许峰律师代理的部分鹏博士（600804）投资者索赔案 再收到法院送达的调解书，投资者将调解获赔。 许峰律师代理的鹏博士投资者索赔案收到法院送达的一审判决书，投资者获得一定比例的胜诉。律师团 队目前还在继续推进后续案件的立案工作，还在继续接受其他投资者的索赔委托。 2024年8月16日晚，鹏博士公告收到证监会《行政处罚决定书》，经查明，当事人违法事实如下： 鹏博士2020-2022年每年年报均减净资产196，000，000.00元，占2020年末、2021年末、2022年末净资 产的比例分别为21.77%、14.27%、18.51%。 2017年-2018年，公司发行"17鹏博债"、"18鹏博债"。其中"17鹏博债"涉及2014年、2015年、2016年、 2017年一季度财务报表，2022年6月已如期兑付。"18鹏博债"涉及2014年、2015年、2016年、2017年三 季度财 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我们！ 上海久诚律师事务所投资者索赔律师许峰提示，倍轻松（维权）（688793）涉嫌虚假陈述引发的投资者 索赔案已经启动。（许峰律师专栏） 2025年12月25日晚，倍轻松（688793）公告收到证监会下发的《立案告知书》，因公司及实际控制人马 学军涉嫌信息披露违法违规，根据《证券法》《行政处罚法》等法律法规，证监会决定对公司立案。 许峰律师认为，暂定在2025年12月26日买入倍轻松股票，并在2025年12月26日后卖出或持有股票的 投资者，目前已可准备发起索赔。（倍轻松维权入口） 除了倍轻松投资者索赔案启动，2025年12月29日，许峰律师代理的部分鹏博士（600804）投资者索赔案 再收到法院送达的调解书，投资者将调解获赔。 许峰律师代理的鹏博士投资者索赔案收到法院送达的一审判决书，投资者获得一定比例的胜诉。律师团 队目前还在继续推进后续案件的立案工 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ （本文由上海市信本律师事务所合伙人赵敬国律师供稿，不代表新浪财经的观点。赵敬国律师，于1999 年取得律师资格，法学理论知识扎实，曾在高校任教。2004年起开始律师执业，承办过千余起各类诉讼 案件，积累了十分丰富的争议处理经验，尤其擅长处理证券纠纷、金融、不良资产等方面的业务。执业 至今，赵敬国律师代理投资者诉多家上市公司索赔案件，已经胜诉或已经获赔的案件包括中安科索赔、 中兵红箭索赔、步森服饰索赔、中潜股份索赔、奥瑞德索赔、獐子岛索赔、天神娱乐索赔、抚顺特钢索 赔、飞乐音响索赔、香溢融通索赔、延安必康索赔、欢瑞世纪索赔、紫晶存储索赔、泽达易盛索赔、安 妮股份索赔等。） 责任编辑：韦子蓉 登录新浪财经APP 搜索【信披】查看更多考评等级 受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我们！ 202 ...